🚀 Exciting News! Introducing TransHeps, a cutting-edge spin-off from the University of Zurich, specializing in groundbreaking laboratory services and advisory expertise for Drug-Induced Liver Injury (DILI) in clinical trials.
🌐 Our Vision: Improve safety during drug therapy by focusing on patient-specific DILI, a rare but potentially life-threatening side effect.
🔍 Our Mission: Make MetaHeps assay a breakthrough tool for DILI causality assessment in clinical studies, serving global pharma developers and regulators.
🛠️ Products & Services: 1. Expert Advisory Services & Consulting around DILI, 2. Exclusive provider of the MetaHeps assay, 3. Tailormade mechanistic in-vitro studies to investigate DILI.
🌟 Differentiation: MetaHeps DILI causality assessment in clinical studies is unrivaled! We are the only industrial service provider of the MetaHeps assay.
👩🔬 Our Team: Seasoned scientists with proven expertise in clinical and experimental hepatology, ensuring top-tier quality standards.
📣 Join us in revolutionizing drug therapy safety! Learn more: https://transheps.com/
Company Details
- Employees
- 2
- Founded
- -
- Address
- Zürich, Schweiz, Zh 8104, Ch
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://transheps.com/
- HQ
- Zürich, Schweiz, ZH
Transheps Questions
Transheps's website is https://transheps.com/
Transheps's LinkedIn profile is https://ch.linkedin.com/company/transheps
Transheps has
2 employees.
View email and phone details for 2
employees at Transheps.
Transheps's industry is
Biotechnology Research
Transheps's top competitors are
Seito Biologics,
Ontrack Biomedical Ag,
Acytronix,
Josepha,
Augmedi,
Versive,
Aiquos,
Apersys Ag,
Roboa,
Firefly Fusion.
Transheps's categories are Biotechnology Research
Transheps's founding year is 2024
